Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for peroxisome biogenesis disorder, complementation group 2.
5 publications have been identified in PubMed for peroxisome biogenesis disorder, complementation group 2. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (40%), and Case Report / Case Series (20%).
Alayoubi AM (2025). [PMID: 39757991](https://pubmed.ncbi.nlm.nih.gov/39757991/). *Ann Med*. [Case Report / Case Series]
Borisyuk A (2025). [PMID: 40689797](https://pubmed.ncbi.nlm.nih.gov/40689797/). *J Cell Biol*. [Basic Science / Preclinical]
Sarkar C (2024). [PMID: 39404418](https://pubmed.ncbi.nlm.nih.gov/39404418/). *Cells*. [Review / Meta-Analysis]
Bajdzienko J (2024). [PMID: 38752931](https://pubmed.ncbi.nlm.nih.gov/38752931/). *J Cell Sci*. [Review / Meta-Analysis]
Villa N (2024). [PMID: 39202220](https://pubmed.ncbi.nlm.nih.gov/39202220/). *Diagnostics (Basel)*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 10:50 PM UTC